Kenya’s Pain Relief Category Gains Momentum Through Affordable Self-Care
The Kenya Analgesics Market was valued at USD 230 Million in 2025 and is estimated at USD 235 Million in 2026, reaching USD 255 Million by 2032 at a CAGR of 1.48%. Systemic analgesics lead with 75% share, while retail offline holds 95%, supported by pharmacy access, affordable OTC pain relief, and household demand for headache, fever, and body pain management.